Source - RNS
RNS Number : 0182N
UDG Healthcare Public Limited Co.
14 January 2019
 

14 January 2019

 

 

 

UDG Healthcare plc

 

Notice of Q1 2019 Trading Update

 

UDG Healthcare plc ("UDG Healthcare" or "Group"), a leading international healthcare services provider, will issue a trading update for the first quarter to 31 December 2018 at 7.00 a.m. (GMT) on Tuesday, 29 January 2019.

 

The Company will also host a conference call for investors and analysts at 9.00am (GMT) on Tuesday, 29 January 2019 to discuss the statement. The dial-in details are as follows:

 

Standard International Access

+44 (0) 20 3003 2666

UK Toll Free

0808 109 0700

Ireland

+353 (0) 1 436 0959

Password

UDG Healthcare

 

A playback facility will be available for seven days on +44 (0) 20 8196 1480. The access code for the replay will be 8581787#.

 

For further information, please contact:

 

Keith Byrne

Head of Investor Relations, Strategy & Corporate Communications

UDG Healthcare plc

Tel: +353-1-468-9000

 

Lisa Kavanagh / Jack Hickey

Powerscourt

Tel: +44-207-250-1446

Email: [email protected]

 

 

About UDG Healthcare plc:

 

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 8,500 people with operations in 26 countries and delivering services in over 50 countries.

 

UDG Healthcare plc operates across two divisions: Ashfield and Sharp.

 

Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of the-art facilities in the US and Europe.

 

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250. For more information, please go to: www.udghealthcare.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NORUSURRKBAAAAR